Cargando…

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Programs that monitor local, national, and regional levels of transmitted HIV-1 drug resistance inform treatment guidelines and provide feedback on the success of HIV-1 treatment and prevention programs. To accurately compare transmitted drug resistance rates across geographic regions and times, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennett, Diane E., Camacho, Ricardo J., Otelea, Dan, Kuritzkes, Daniel R., Fleury, Hervé, Kiuchi, Mark, Heneine, Walid, Kantor, Rami, Jordan, Michael R., Schapiro, Jonathan M., Vandamme, Anne-Mieke, Sandstrom, Paul, Boucher, Charles A. B., van de Vijver, David, Rhee, Soo-Yon, Liu, Tommy F., Pillay, Deenan, Shafer, Robert W.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648874/ https://www.ncbi.nlm.nih.gov/pubmed/19266092 http://dx.doi.org/10.1371/journal.pone.0004724

Ejemplares similares

The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance
por: Gifford, Robert J., et al.
Publicado: (2009)

Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2023)

Temporal Trends in HIV-1 Mutations Used for the Surveillance of Transmitted Drug Resistance
por: Rhee, Soo-Yon, et al.
Publicado: (2021)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
por: Castro, Hannah, et al.
Publicado: (2012)

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group
por: Frentz, Dineke, et al.
Publicado: (2014)

HIV‐1 transmitted drug resistance surveillance: shifting trends in study design and prevalence estimates
por: Rhee, Soo‐Yon, et al.
Publicado: (2020)

Surveillance of HIV Transmitted Drug Resistance in Latin America and the Caribbean: A Systematic Review and Meta-Analysis
por: Avila-Rios, Santiago, et al.
Publicado: (2016)

Recommendations on data sharing in HIV drug resistance research
por: Inzaule, Seth C., et al.
Publicado: (2023)

Highly-Sensitive Allele-Specific PCR Testing Identifies a Greater Prevalence of Transmitted HIV Drug Resistance in Japan
por: Nishizawa, Masako, et al.
Publicado: (2013)

Persistence of HIV-1 Transmitted Drug Resistance Mutations
por: Castro, Hannah, et al.
Publicado: (2013)

Genetic Variability of HIV-1 for Drug Resistance Assay Development
por: Clutter, Dana S., et al.
Publicado: (2016)

Response to Therapy in Antiretroviral Therapy–Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor–Associated Transmitted Drug Resistance
por: Clutter, Dana S., et al.
Publicado: (2016)

A16 Next-generation sequencing to detect transmitted drug resistance mutations in Romanian people who inject drugs
por: Surleac, Marius, et al.
Publicado: (2019)

How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact
por: Dimitrov, Dobromir T., et al.
Publicado: (2016)

More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
por: Feder, Alison F, et al.
Publicado: (2016)

Simple PCR Assays Improve the Sensitivity of HIV-1 Subtype B Drug Resistance Testing and Allow Linking of Resistance Mutations
por: Johnson, Jeffrey A., et al.
Publicado: (2007)

Human Immunodeficiency Virus Drug Resistance: 2018 Recommendations of the International Antiviral Society–USA Panel
por: Günthard, Huldrych F, et al.
Publicado: (2019)

Correction: More effective drugs lead to harder selective sweeps in the evolution of drug resistance in HIV-1
por: Feder, Alison F, et al.
Publicado: (2017)

Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations
por: Pingarilho, Marta, et al.
Publicado: (2020)

Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population
por: Rhee, Soo-Yon, et al.
Publicado: (2019)

Functional conservation of HIV-1 Gag: implications for rational drug design
por: Li, Guangdi, et al.
Publicado: (2013)

Combination antiretroviral therapy and cell–cell spread of wild-type and drug-resistant human immunodeficiency virus-1
por: Titanji, Boghuma Kabisen, et al.
Publicado: (2017)

Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic
por: Pineda-Peña, Andrea-Clemencia, et al.
Publicado: (2014)

Public availability of HIV-1 drug resistance sequence and treatment data: a systematic review
por: Rhee, Soo-Yon, et al.
Publicado: (2022)

The changing face of HIV resistance; HIV drug resistance north and south — what's next?
por: Schapiro, J
Publicado: (2010)

Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy
por: Nishizawa, Masako, et al.
Publicado: (2015)

Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness
por: Martin, Supang A., et al.
Publicado: (2021)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
por: Theys, Kristof, et al.
Publicado: (2010)

Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy
por: Johnson, Jeffrey A, et al.
Publicado: (2008)

Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
por: Rhee, Soo-Yon, et al.
Publicado: (2015)

Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation
por: Paredes, Roger, et al.
Publicado: (2017)

Statewide Longitudinal Trends in Transmitted HIV-1 Drug Resistance in Rhode Island, USA
por: Novitsky, Vlad, et al.
Publicado: (2021)

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing
por: Rhee, Soo-Yon, et al.
Publicado: (2015)

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
por: Ávila-Ríos, Santiago, et al.
Publicado: (2020)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
por: Rhee, Soo-Yon, et al.
Publicado: (2015)

National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2011)

Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals
por: Winand, Raf, et al.
Publicado: (2015)

Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations
por: Monge, Susana, et al.
Publicado: (2014)

Antiretroviral Treatment Simplification With 2-Drug Regimens: Impact of Transmitted Drug Resistance Mutations
por: Kessler, Harald H, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vhih572f7ogtv7c223gabi5flp